SYNLOGIC, INC. Debt Securities, Available-for-sale, Noncurrent
SYNLOGIC, INC. (SYBX) had Debt Securities, Available-for-sale, Noncurrent of $8.04 million as of 2021-12-31, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2023-03-29
- 2021-12-31: Debt Securities, Available-for-sale, Noncurrent $8.04M.
- 2019-12-31: Debt Securities, Available-for-sale, Noncurrent $7.50M.
- 2019-09-30: Debt Securities, Available-for-sale, Noncurrent $18.40M.
- 2019-06-30: Debt Securities, Available-for-sale, Noncurrent $20.06M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2021-12-31 | $8.04M 10-K · filed 2023-03-29 |
| 2019-12-31 | $7.50M 10-K · filed 2021-03-25 |
| 2019-09-30 | $18.40M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $20.06M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |